Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 954-921-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8 Mar 2016 to 5 Apr 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Version / remarks:
- 2018
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- 2002
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2008
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- 4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl)-N-(2-ethyl-3-oxo-1,2-oxazolidin-4-yl)-2-methylbenzamide
- Cas Number:
- 2061933-85-3
- Molecular formula:
- C23H19Cl2F4N3O4
- IUPAC Name:
- 4-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl)-N-(2-ethyl-3-oxo-1,2-oxazolidin-4-yl)-2-methylbenzamide
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl:(WI)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Sex: Female rat, nulliparous and non-pregnant
- Age: Young adult rats, 8 weeks old
- Body weight when treated: 199 – 216 g
- Fasting period: animals were fasted overnight prior to treatment and food was returned approximately 3 hours after dosing
- Diet: Animals received "Autoclavable complete diet for rats and mice – breeding and maintenance" ad libitum
- Water: Tap water from municipal supply, provided in 500 mL bottles ad libitum
- Housing: Individual caging Type II. polypropylene/polycarbonate cages. Laboratory bedding were available to animals during the study
- Acclimatisation period: At least 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.0 – 21.9
- Humidity (%): 26 – 70
- Air changes (exchanges/hour): 15 - 20
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: from 08 Mar 2016 to 05 Apr 2016
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.5 % (w/v) carboxymethyl cellulose and 0.1 % (v/v) Tween 80
- Details on oral exposure:
- The applied dose volume was 10 mL/kg bw
- Doses:
- Starting dose of 1750 mg/kg bw, then 5000 mg/kg bw as no clinical signs or lethality were observed, followed by a 14 day observation period. Animals were treated with a single oral (gavage) dose.
- No. of animals per sex per dose:
- 4
- Control animals:
- no
- Details on study design:
- All animals were observed individually after dosing at 30 minutes, then 1, 2, 3, 4, and 6 hours after dosing and once each day for 14 days thereafter. Individual observations were performed on the skin and fur, eyes and mucous membranes and also respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The body weights were recorded on Days -1, 0 (before treatment), 7 and 14. All animals were euthanised at the end of the observation period by exsanguination under pentobarbital anaesthesia and all animals were subjected to macroscopic examination. After examination of the external appearance, the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs were observed. All gross pathological changes were recorded for each animal on the post mortem record sheets and the animals were discarded.
- Statistics:
- The oral LD50 was calculated using the statistical programme (AOT 425 Stat Pgm) version: 1.0, 2001, used for the selection of dose levels and calculation of the LD50 values.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- >= 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study.
- Clinical signs:
- other: No clinical signs were observed during the observation period.
- Gross pathology:
- At necropsy, there were no observations to be reported at a dose level of 1750 and 5000 mg/kg bw.
Any other information on results incl. tables
Table 1: Acute oral toxicity of the test substance in rats, application scheme and mortality data
Animal Number |
Dose [mg/kg body weight] |
Volume Dosed [mL] |
Bodyweight [g] |
Mortality |
1 |
1750 |
2.1 |
207 |
Survived |
2 |
5000 |
2.0 |
199 |
Survived |
3 |
5000 |
2.0 |
199 |
Survived |
4 |
5000 |
2.2 |
216 |
Survived |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the acute oral median lethal dose (LD50) of the test substance was greater than 5000 mg/kg bw in female Crl:WI rats.
- Executive summary:
An acute oral toxicity study (OECD 425, GLP compliant) (up and down procedure) was conducted with 4 female Crl:WI rats. Animals were treated with a single oral (gavage) dose of the test substance, at a dose level of 1750 or 5000 mg/kg body weight (bw) followed by a 14 day observation period. The animals were fasted overnight prior to treatment and food was returned 3 hours after dosing. Animals were observed individually after dosing at 30 minutes, then at 1, 2, 3, 4 and 6 hours post treatment and once each day for 14 days, thereafter. Body weight was measured on Day -1, just before dosing and weekly thereafter. All animals were examined macroscopically at the end of the observation period. There was no mortality during the study. No clinical signs were observed during the observation period. There were no treatment related effects on body weight or body weight gain. Body weights were within the range commonly recorded for this strain and age. At necropsy, there were no observations to be reported at a dose level of 1750 and 5000 mg/kg bw.
Under the conditions of this study, the acute oral median lethal dose (LD50) of the test substance, the test substance, was greater than 5000 mg/kg bw in female Crl:WI rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
